Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FGNLS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,785
Award facts
- Contract value 100% obligated
- $46,785.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) injectable medication in 3 mL vials. This competitively awarded, firm fixed-price delivery order has a ceiling value of $46,785.49 and an ultimate completion date of April 25, 2025. The award utilizes no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp serves multiple government healthcare systems including the Defense Health Agency and U.S. Coast Guard through its comprehensive IDC vehicle. The DLA Troop Support Medical contract functions as a global pharmaceutical support program enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains in support of military healthcare programs worldwide. This delivery order for Ozempic, a diabetes medication, reflects AmerisourceBergen's role in supplying essential pharmaceutical products to federal health systems through the DLA's Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FGNLS?
SPE2DB25FGNLS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FGNLS worth?
The government has obligated $46,785 on SPE2DB25FGNLS.
Is contract SPE2DB25FGNLS an order under another contract?
Yes. SPE2DB25FGNLS is a delivery order under SPE2DB24D2216, an indefinite delivery contract.
Was contract SPE2DB25FGNLS competed?
The extent of competition for SPE2DB25FGNLS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award